Efficacy of Early Administration of Tocilizumab in COVID-19 Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The clinical study aims at assessing whether early administration of Tocilizumab compared to late administration of Tocilizumab can reduce the number of patients with COVID-19 pneumonia who require mechanical ventilation. The clinical study includes patients with recent-onset COVID-19 pneumonia who require hospital care, but not invasive or semi-invasive mechanical ventilation procedures.
Epistemonikos ID: 13f0f3cf1ed34de1b96a815d250d105ad0aedd6a
First added on: Apr 16, 2020